Several clinical trials have consistently shown that antihypertensive treatment, particularly with angiotensin-converting enzyme inhibitors (ACE-I) reduces albuminuria in Type 1 diabetic patients. More recently, data on the beneficial effects of ACE-I on the preservation of glomerular filtration rate and renal ultrastructure have emerged. However, in general, these trials have recruited a wide spectrum of diabetics, including some patients with severe albuminuria. Thus, the question of the ideal stage at which to instigate what is likely to be lifelong therapy in young people still remains unanswered.
Exercise is known to significantly increase both blood pressure (BP) and urinary albumin excretion (UAE), both of which are important determinants of progression of nephropathy in diabetes. Thus, it is possible that exercise may have an adverse effect on diabetic renal disease. The effects of ACE-I on exercise-BP and exercise-UAE in microalbuminuric Type 1 diabetic patients has not been examined in long-term placebo-controlled studies.
In the second part of this two-part review, we examine the effects of the ACE-I, lisinopril, 20 mg o.d. for two years, in comparison with placebo, on UAE, 24-hour ambulatory BP, exercise-BP, exercise-UAE and renal haemodynamics in 22 patients with Type 1 diabetes and low-grade microalbuminuria. We further discuss the effects of ACE-I on nephropathy and other complications of diabetes.
Andersen AR, Christiansen JS, Andersen JK, Kreiner S., Deckert T.Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia1983;25:496-501.
2.
Krolewski AS , Warram JH, Christlieb ARThe changing natural history of nephropathy in type I diabetes. Am J Med1985;78:785-94.
3.
Kofoed Enevoldsen A., Borch-Johnsen K., Kreiner S., Nerup J., Deckert T.Declining incidence of persistent proteinuria in type 1 (insulin-dependent) diabetic patients in Denmark. Diabetes1987;36:205-09.
4.
Rossing P., Rossing K., Jacobsen P., Parving H-H.Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes1995;44:739-43.
5.
Wang PH, Lau J., Chalmers TCMeta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet1993 ;341:1306-09.
6.
Tarnow L., Cambien F., Rossing P. et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes1995 ;44:489-94.
7.
Viberti GC, Hill RD, Jarrett RJ,Argyropoulos A., Mahmud U., Keen H.Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet1982; I:1430-2.
8.
Parving H-H. , Oxenboll B., Johansen K., Svendsen PA, Christiansen JS, Andersen AREarly detection of patients at risk of developing diabetic nephropathy: a longitudinal study of 100:500-05. urinary albumin excretion. Acta Endocrinol Copenh1982;
9.
Mogensen CE, Christensen CKPredicting diabetic nephropathy in insulin-dependent patients. N Engl JMed1984;311:89-93.
10.
Mathiesen ER , Oxenboll B., Johansen K., Svendsen PA, Deckert T.Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia1984;26:406-10.
11.
Mogensen CEMicroalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia1999;42:263-85.
12.
Wiseman M., Viberti G., Mackintosh D., Jarrett RJ, Keen H.Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia1984; 26:401-05.
13.
Feldt Rasmussen B., Borch-Johnsen K., Mathiesen ERHypertension in diabetes as related to nephropathy. Early blood pressure changes. Hypertension1985;7:1118-1120.
14.
Hansen KW, Christensen CK,Andersen PH, Pedersen MM, Christiansen JS, Mogensen CEAmbulatory blood pressure in microalbuminuric type 1 diabetic patients . Kidney Int1992;41:847-54.
15.
Hansen KW, Mau Pedersen M., Marshall SM, Christiansen JS, Mogensen CECircadian variation of blood pressure in patients with diabetic nephropathy . Diabetologia1992; 35:1074-9.
16.
Moore WV, Donaldson DL, ChonkoAM,Ideus P.,Wiegmann TBAmbulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes1992;41:1035-41.
17.
Benhamou PY , Halimi S., De Gaudemaris R. et al. Early disturbances of ambulatory blood pressure load in normotensive type I diabetic patients with microalbuminuria . Diabetes Care1992 ;15:1614-19.
18.
Berrut G., Hallab M., Bouhanick B., Chameau AM, Marre M., Fressinaud P.Value of ambulatory blood pressure monitoring in Type I (Insulin-Dependent) diabetic patients with incipient diabetic nephropathy.AmJHypertens1994;7:222-7.
19.
Poulsen PL, Ebbehøj E., Hansen KW, Mogensen CEElevated ambulatory blood pressure in microalbuminuric IDDM patients is inversely related with renal plasma flow - a compensatory mechanism?Diabetes Care1997;20:429-32.
20.
Marre M., Chatellier G., Leblanc H., Guyene TT, Menard J., Passa P.Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ1988; 297:1092-5.
21.
Rudberg S., Aperia A., Freyschuss U., Persson B.Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia1990;33:470-6.
22.
Mathiesen ER , Hommel E., Giese J., Parving H-H .Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria . BMJ1991;303:81-7.
23.
Viberti G., Mogensen CE, Groop LC, Pauls JFEffect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA1994;271:275-9.
24.
The EUCLID Study Group: Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet1997;349:1787-92.
25.
Mathiesen ER , Hommel E., Hansen HP, Smidt UM, Parving H-H .Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ1999;319:24-5.
26.
Rudberg S., sterby R., Bangstad HJ, Dahlquist G., Persson B.Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus. Diabetologia1999;42:589-95.
Microalbuminuria Collaborative Study Group, UK: Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. BMJ1993;306:1235-9.
29.
Poulsen PL, Hansen KW, Mogensen CEAmbulatory blood pressure in the transition from normo- to microalbuminuria.A longitudinal study in IDDM patients. Diabetes1994;43:1248-53.
30.
Mathiesen ER , Ronn B., Storm B., Foght H., Deckert T.The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study . Diabet Med1995;12:482-7.
31.
Voros P., Lengyel Z., Nagy V.,Nemeth C., Rosivall L., Kammerer L.Diurnal blood pressure variation and albuminuria in normotensive patients with insulin-dependent diabetes mellitus. Nephrol Dial Transplant1998;13:2257-60.
32.
Mølgaard H. , Christensen PD, Sørensen KE, Christensen CK, Mogensen CEAssociation of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM patients. A Diabetes1992;41:812-17.
33.
Mølgaard H. , Christensen PD, Hermansen K., Sørensen KE, Christensen CK, Mogensen CEEarly recognition of autonomic dysfunction in microalbuminuria: significance for cardiovascular mortality in diabetes mellitus?Diabetologia1994;37:78896.
34.
Jensen T., Stender S., Deckert T.Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia1988;31:142-5.
35.
Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H., Viberti GCPlasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ1989; 298:487-90.
36.
Jensen T., Bjerre Knudsen J., Feldt Rasmussen B., Deckert T.thy. Lancet1989;1:461-3. Features of endothelial dysfunction in early diabetic nephropa
37.
Stehouwer CD , Stroes ES, Hackeng WH, Mulder PG, den Ottolander GJvon Willebrand factor and development of diabetic nephropathy in IDDM [published erratum appears in Diabetes 1991 Dec;40(12):1746.]Diabetes1991;40:971-6.
38.
Dogra G., Rich L., Stanton K., Watts GFEndothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia2001;44:593-601.
39.
Parving H-H. , Hommel E., Mathiesen E. et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. BMJ1988;296:156-60.
40.
Chavers BM, Mauer SM, Ramsay RC, Steffes MWRelationship between retinal and glomerular lesions in IDDM patients . Diabetes1994;43:441-6.
41.
Ekbom P., Damm P., Nogaard K. et al. Urinary albumin excretion and 24-hour blood pressure as predictors of pre-eclampsia in Type I diabetes.Diabetologia2000;43:927-31.
42.
Bangstad HJ , sterby R., Dahl Jorgensen K. et al. Early glomerulopathy is present in young, Type 1 (insulin-dependent) diabetic patients with microalbuminuria . Diabetologia1993;36:523-9.
43.
sterby R., Bangstad HJ, Nyberg G.,Walker JD,Viberti GCA quantitative ultrastructural study of juxtaglomerular arterioles in IDDM patients with micro- and normoalbuminuria. Diabetologia1995;38:1320-7.
44.
Jensen JS, Feldt-Rasmussen B., Strandgaard S., Schroll M., Borch-Johnsen K.Arterial hypertension, microalbuminuria, and risk of ischemic heart disease . Hypertension2000;35:898-903.
45.
Kasiske BL, Kalil RS, Ma JZ, Liao M., Keane WFEffect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med1993; 118:129-38.
46.
Poulsen PLBlood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes. JRAAS2002;3:222-42.
47.
Mogensen CE , Keane WF, Bennett PH et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet1995;346:1080-4.
48.
Cooper MEPathogenesis, prevention, and treatment of diabetic nephropathy. Lancet1998;352:213-19.
49.
Pedersen MM , Schmitz A., Pedersen EB, Danielsen H., Christiansen JSAcute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Diabet Med1988;5:562-9.
50.
Kvetny J., Gregersen G., Pedersen R.Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus. QJM2001;94:89-94.
51.
Mogensen CE , Hansen KW, sterby R., Damsgaard EMBlood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes. Diabetes Care1992;15:1192-204.
52.
Hansen KW, Klein F., Christensen PD et al. Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patients. Diabet Metab1994;20:485-93.
53.
Karlefors T.Haemodynamic studies in male diabetics. Acta Med Scand1966;449(suppl):45-80.
54.
Mogensen CE , Vittinghus E., Sølling K.Abnormal albumin excretion after two provocative renal tests in diabetes: physical exercise and lysine injection. Kidney Int1979;16:385-93.
55.
Vittinghus E., Mogensen CEGraded exercise and protein excretion in diabetic man and the effect of insulin treatment. Kidney Int1982;21:725-9.
56.
Christensen CKAbnormal albuminuria and blood pressure rise in incipient diabetic nephropathy induced by exercise. Kidney Int1984;25:819-23.
57.
Rossing P., Hommel E., Smidt UM, Parving H-H.Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes1993 ;42:71519.
58.
Watkins PJ, Blainey JD, Brewer DB et al.The natural history of diabetic renal disease. QJM1972;41:437-56.
59.
Parving H-H. , Rossing P., Hommel E., Smidt UMAngiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience. Am J Kidney Dis1995;26:99-107.
60.
Remuzzi G., Bertani T.Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?Kidney Int1990;38:384-94.
61.
Hebert LA, Agarwal G., Sedmak DD, Mahan JD, Becker W., Nagaraja HNProximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria. Kidney Int2000;57:1962-7.
62.
Koivisto VA , Huttunen NP, Vierikko P.Continuous subcutaneous insulin infusion corrects exercise-induced albuminuria in juvenile diabetes . BMJ1981;282:778-9.
63.
Viberti G., Pickup JC, Bilous RW, Keen H., Mackintosh D.Correction of exercise-induced microalbuminuria in insulin-dependent diabetics after 3 weeks of subcutaneous insulin infusion. Diabetes1981;30:818-23.
64.
Mogensen CE , Christensen CK,Vittinghus E.The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy . Diabetes1983;32(suppl 2):64-78.
65.
Poulsen PL, Ebbehøj E., Nosadini R., Crepaldi G., Mogensen CEEarly ACE-I intervention in microalbuminuric patients with type 1 diabetes: Effects on albumin excretion, 24 h ambulatory blood pressure, and renal function . Diabet Metab2001;27:123-8.
66.
Crepaldi G. , Carta Q., Deferrari G. et al. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM . Diabetes Care1998;21:104-10.
67.
Poulsen PL, Ebbehøj E., Mogensen CELisinopril reduces albuminuria during exercise in low grade microalbuminuric Type 1 diabetic patients: A double blind randomized study. J Intern Med2001;249(5):433-40.
68.
Hansen KW, Poulsen PL, Mogensen CEAmbulatory blood pressure and abnormal albuminuria in type 1 diabetic patients . Kidney Int1994;45(suppl):S134-S140.
69.
Hansen KW, Poulsen PL, Christiansen JS, Mogensen CEDeterminants of 24-h blood pressure in IDDM patients. Diabetes Care1995;18:529-35.
70.
Mogensen CEGlomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest1971;28:91-100.
71.
Hansen KW, Mau Pedersen M., Christensen CK, Schmitz A., Christiansen JS, Mogensen CENormoalbuminuria ensures no reduction of renal function in type 1 (insulin-dependent) diabetic patients.J Intern Med1992;232:161-7.
72.
Mogensen CE, Hansen KW, Nielsen S., Pedersen MM, Rehling M., Schmitz A.Monitoring diabetic nephropathy: Glomerular filtration rate and abnormal albuminuria in diabetic renal disease - reproduceability, progression and efficacy of antihypertensive intervention. Am J Kidney Dis1993;22:174-87.
73.
Zatz R., Dunn BR, Meyer TW, Anderson S., Rennke HG, Brenner BMPrevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest1986 ;77:1925-30.
74.
Imanishi M. ,Yoshioka K., Konishi Y. et al. Glomerular hypertension as one cause of albuminuria in type II diabetic patients. Diabetologia1999;42:999-1005.
75.
Christiansen JSOn the pathogenesis of the increased glomerular filtration rate in short-term insulin-dependent diabetes. Dan Med Bull1984;31:349-61.
76.
Parving H-H. , Hommel E., Smidt UMProtection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy . BMJ1988;297:1086-91.
77.
Elving LD, Wetzels JF, de Nobel E., Hoitsma AJ, Berden JHCaptopril acutely lowers albuminuria in normotensive patients with diabetic nephropathy. Am J Kidney Dis1992 ;20:559-63.
78.
Feldt Rasmussen B., Baker L., Deckert T.Exercise as a provocative test in early renal disease in type 1 (insulin-dependent) diabetes: albuminuric, systemic and renal haemodynamic responses. Diabetologia1985;28:389-96.
79.
Romanelli G. , Giustina A., Cimino A. et al. Short term effect of captopril on microalbuminuria induced by exercise in normotensive diabetics . BMJ1989;298:284-8.
80.
Romanelli G. , Giustina A., Bossoni S. et al. Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. Diabetes1990 ;39:1333-8.
81.
Christensen CK, Mogensen CEAcute and long-term effect of antihypertensive treatment on exercise-induced albuminuria in incipient diabetic nephropathy . Scand J Clin Lab Invest1986;46:553-9.
82.
Tuominen JA , Ebeling P., Koivisto VA . Long-term lisinopril therapy reduces exercise-induced albuminuria in normoalbuminuric normotensive IDDM patients. Diabetes Care1998;21:1345-8.
83.
Rossing P., Hougaard P., Borch-Johnsen K., Parving H-H.Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ1996;313:779-84.
84.
Messent JW, Elliott TG, Hill RD, Jarrett RJ, Keen H., Viberti GCPrognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int1992;41:836-9.
85.
Caramori ML , Fioretto P., Mauer M.The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?Diabetes2000;49:1399-408.
86.
Fioretto P. , Steffes MW, Mauer M.Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes1994;43:1358-64.
87.
Forsblom CM , Groop PH, EkstrandA ,Groop LCPredictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. BMJ1992;305:1051-3.
88.
Rossing P., Hougaard P., Borch-Johnsen K., Parving H-H.Progression from microalbuminuria to diabetic nephropathy in IDDM . J Am Soc Nephrol1997;8:(abstract).
89.
Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria.The Microalbuminuria Captopril Study Group. Diabetologia1996;39:587-93.
90.
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med2000;342:381-9.
91.
sterby R.Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologia1992;35:803-12.
92.
Franken AA, Derkx FH, Blankestijn PJ et al. Plasma prorenin as an early marker of microvascular disease in patients with diabetes mellitus. Diabet Metab1992;18:137-43.
93.
Daneman D., Crompton CH, Balfe JW et al. Plasma prorenin as an early marker of nephropathy in diabetic (IDDM) adolescents. Kidney Int1994;46:1154-9.
94.
Allen,TJ, Cooper ME, Gilbert RE,Winikoff J., Skinni SL, Jerums G.Serum total renin is increased before microalbuminuria in diabetes . Kidney Int1996;50:902-07.
95.
Deinum J., Ronn B., Mathiesen E., Derkx FH, Hop WC, Schalekamp MAIncrease in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia1999;42:1006-10.
96.
Jensen T.Increased plasma concentration of von Willebrand factor in insulin dependent diabetics with incipient nephropathy. BMJ1989;298:27-8.
97.
Coonrod BA, Ellis D., Becker DJ et al. Predictors of Microalbuminuria in Individuals with IDDM. Pittsburg Epidemiology of Diabetes Complication Study. Diabetes Care1993;16:1376-83.
98.
Chaturvedi N., Bandinelli S., Mangili R., Penno G., Rottiers R., Fuller JHMicroalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int2001;60:219-27.
99.
Watts GF, Powrie JK, O'Brien SF, Shaw KMApolipoprotein B independently predicts progression of very-low-level albuminuria in insulin-dependent diabetes mellitus. Metabolism1996;45:1101-07.
100.
Moorhead JF , Chan MK, El Nahas M., Varghese Z.Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet1982;2:1309-11.
101.
Bojestig M. , Karlberg B., Lindström T., Nystrom F.Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes . Diabetes Care2001;24(5):919-24.
102.
The ATLANTIS Study Group.Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial. Diabetes Care2000;23:1823-9.
103.
Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT). Diabetes2001;50:843-50.
104.
Heart Outcomes PreventionEvaluation Study Investigators.Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet2000;355:253-9.
105.
Hansson L. , Lindholm LH, Niskanen L. et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet1999;353:611-16.
106.
Jensen T.The HOPE study and diabetes. Heart Outcomes Prevention Evaluation . Lancet2000;355:1181-4.
107.
Chaturvedi N., Sjolie AK, Stephenson JM et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes.The EUCLID Study Group. EURO-DIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.Lancet1998;351:28-31.
108.
Chase HP, Satish K., Harris S., Hoops S., Jackson WE, Holmes DLAngiotensin-converting enzyme inhibitor treatment for young normotensive diabetic subjects: A two-year trial. Ann Ophthalmol1993;25:284-9.
109.
Larsen M., Hommel E., Parving H-H., Lund-Andersen H.Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy . Graefes Arch Clin Exp Ophthalmol1990;228:505-09.
110.
Jackson WE , Holmes DL, Garg SK, Harris S., Chase HPAngiotensin-converting enzyme inhibitor therapy and diabetic retinopathy. Ann Ophthalmol1992 ;24:99-103.
111.
UKPDS 38. UK Prospective Diabetes Study Group.Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: [published erratum appears in BMJ 1999 Jan 2;318(7175):29]. BMJ1998; 317:703-13.
112.
UKPDS 39. UK Prospective Diabetes Study Group.Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. BMJ1998;317:713-20.
113.
Forrest KY , Maser RE, Pambianco G., Becker DJ, Orchard TJHypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes1997;46:665-70.
114.
Reja A., Tesfaye S., Harris ND, Ward JDIs ACE inhibition with lisinopril helpful in diabetic neuropathy?Diabet Med1995;12:307-09.
115.
Malik RA, Williamson S., Abbott C. et al. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet1998; 352:1978-81.
116.
Moore MV, Jeffcoate WJ, Macdonald IAApparent improvement in diabetic autonomic neuropathy induced by captopril .JHum Hypertens1987;1:161-5.
117.
Athyros VG, Didangelos TP, Karamitsos DT, Papageorgiou AA, Boudoulas H., Kontopoulos AGLong-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy . Acta Cardiol1998;53:201-09.
118.
Salo TM, Viikari JS, Antila KJ, Voipio-Pulkki LM, Jalonen JO, Valimaki IAAntihypertensive treatment and heart rate variability in diabetic patients: role of cardiac autonomic neuropathy. J Auton Nerv Syst1996;60:61-70.
119.
Malik RACan diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?Ann Med2000; 32:1-5.
120.
Poulsen PL , Ebbehøj E., Hansen KW, Mogensen CE24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia1997;40:718-25.
121.
Poulsen PL , Hansen KW, Ebbehøj E., Knudsen ST, Mogensen CENo deleterious effects of tight blood glucose control on 24-hour ambulatory blood pressure in normoalbuminuric insulin-dependent diabetes mellitus patients. J Clin Endocrinol Metab2000;85:155-8.
122.
Poulsen PL , Ebbehøj E., Hansen KW, Mogensen CEEffects of smoking on 24-h ambulatory blood pressure and autonomic function in normoalbuminuric insulin-dependent diabetes mellitus patients. Am J Hypertens1998;11:1093-9.
123.
Poulsen PL , Bek T., Ebbehøj E., Hansen KW, Mogensen CE24-h ambulatory blood pressure and retinopathy in normoalbuminuric IDDM patients. Diabetologia1998;41:105-10.
124.
Poulsen PL , Ebbehøj E., Knudsen S. et al. Increased QTc dispersion is related to blunted circadian blood pressure variation in normoalbuminuric type 1 diabetic patients. Diabetes2001;50(4):837-42.
